Notícias Rogers - ROG

Serviços em Tempo-Real
Real-time Level 1 for Canada + USA
Assinatura Mensal
por apenas
US$38,05
Trader Plus
Assinatura Mensal
por apenas
US$31,91
Trade Alert US
Assinatura Mensal
por apenas
US$67,09
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo Código ISIN do Ativo Descrição da Ação
Rogers ROG NYSE Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Preço Máximo Preço Mínimo Preço de Abertura Preço de Fechamento Hora
  0,00 0,00% 142,04 0,00 0,00 0,00 142,04 04:59:55
mais cotações »

Notícias Recentes

Data Hora Fonte Título
16/05/201902:03ONERoche announces FDA approval for Venclexta plus Gazyva for..
16/05/201902:00ONERoche's personalised medicine entrectinib shrank tumours..
14/05/201902:03ONENew Roche test aids clinicians in accelerating tuberculosis..
14/05/201902:00ONERoche and Spark Therapeutics, Inc. announce expected..
10/05/201902:00ONERoche to present new data highlighting comprehensive..
08/05/201902:00ONERoche présente de nouvelles analyses sur OCREVUS..
08/05/201902:00ONERoche to present new OCREVUS (ocrelizumab) data analyses..
08/05/201902:00ONERoche stellt am AAN-Kongress neue Daten zu OCREVUS..
07/05/201902:00ONERoche presents data from the risdiplam pivotal FIREFISH and..
06/05/201902:00ONEFDA approves Roche's Kadcyla for adjuvant treatment of..
01/05/201911:30PAPERBREstados Unidos: Índice Dow Jones abre praticamente estável..
30/04/201917:09BWRogers Corporation Reports First Quarter 2019 Results
29/04/201902:00ONENew Roche data at the 2019 AAN Annual Meeting showcase..
23/04/201902:00ONERoche launches new VENTANA HER2 Dual ISH companion..
17/04/201902:00ONERoche startet mit starkem Umsatzwachstum ins Jahr 2019 und..
17/04/201902:00ONERoche fait état de solides résultats sur les trois premiers..
17/04/201902:00ONERoche reports a strong start in 2019 and raises the outlook..
10/04/201918:09BWRogers Schedules Q1 2019 Earnings Call for April 30, 2019
03/04/201902:00ONERoche and Spark Therapeutics, Inc. announce withdrawal and..
01/04/201902:00ONERoche's ipatasertib in combination with Tecentriq and..
26/03/201911:00PRNUSGriswold® Announces FlameSafe™, the Industry's First Family..
19/03/201903:00ONEFDA approves Roche's Tecentriq in combination with..
15/03/201903:00ONEEuropean Commission approves Roche's MabThera (rituximab)..
14/03/201903:00ONEEuropean Commission approves Roche's Hemlibra for people..
11/03/201903:03ONERoche's VENTANA PD-L1 (SP142) Assay approved as first..
11/03/201903:00ONEFDA grants Roche's Tecentriq in combination with Abraxane..
08/03/201903:00ONEEuropean Commission approves Roche's Tecentriq in..
07/03/201913:35ONERoche commences tender offer for all shares of Spark..
07/03/201910:38ONERoche submits supplemental new drug application to FDA for..
05/03/201910:23ONEAssemblée générale Roche 2019
05/03/201910:23ONERoche Annual General Meeting 2019
05/03/201910:23ONERoche Generalversammlung 2019
28/02/201913:35ONEFDA approves Herceptin Hylecta for subcutaneous injection in..
25/02/201903:00ONERoche enters into definitive merger agreement to acquire..
21/02/201912:30PAPERBREstados Unidos: Índice Dow Jones abre praticamente estável..
20/02/201918:09BWRogers Corporation Reports Fourth Quarter 2018 and Full Year..
19/02/201903:03ONEFDA grants Priority Review to Roche's personalised medicine..
19/02/201903:00ONEFDA grants Priority Review to Roche's polatuzumab vedotin in..
07/02/201920:01BWRogers Schedules Q4 & Full Year 2018 Earnings Call for..
06/02/201904:00ONERoche joins the World Federation of Hemophilia Humanitarian..
05/02/201904:00ONERoche submits supplemental biologics license application to..
01/02/201911:15ONECHMP recommends EU approval of Roche's Hemlibra for people..
01/02/201911:10ONECHMP recommends EU approval of Roche's Tecentriq in..
31/01/201904:00ONERoche mit sehr gutem Jahresergebnis für 2018
31/01/201904:00ONERoche fait état de très bons résultats pour 2018
31/01/201904:00ONERoche reports very strong results in 2018
30/01/201904:00ONERoche to discontinue Phase III CREAD 1 and 2 clinical..
17/01/201904:00ONEFDA accepts Roche's supplemental biologics license..
11/01/201915:32BWRogers to Participate in Needham Growth Conference
07/01/201919:42BWRogers to Participate in CJS Investor Conference
Acessar notícias de todos os ativos »
Seu Histórico Recente
NYSE
ROG
Rogers
Registre-se agora para acompanhar essas ações ao vivo no Monitor ADVFN.

O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é completamente grátis para você usar.

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

P: V: D:20190520 10:26:23